# Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

> **NCT06048536** · PHASE2 · COMPLETED · sponsor: **Mylan Pharmaceuticals Inc** · enrollment: 168 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** MR-130A-01 Transdermal patch
- **DRUG:** MR-130A-01 Transdermal patch
- **DRUG:** MR-130A-01 Transdermal patch
- **DRUG:** MR-130A-01 Transdermal patch

## Key facts

- **NCT ID:** NCT06048536
- **Lead sponsor:** Mylan Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-22
- **Primary completion:** 2024-01-18
- **Final completion:** 2024-01-18
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06048536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06048536, "Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06048536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*